Combined naloxone and fluoxetine on deprivation-induced binge eating of palatable foods in rats

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 4, 1997, Pages 1103-1107

  Hagan, M M ^a   Holguin, F D ^a   Cabello, C E ^a   Hanscom, D R ^a   Moss, D E ^a  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

Animal model; Binge eating; Bulimia; Carbohydrate; Fat; Fluoxetine; Foodintake; Hyperphagia; Naloxone; Palatable food; Rats

Indexed keywords

FLUOXETINE; NALOXONE;

ANIMAL EXPERIMENT; ARTICLE; BINGE EATING DISORDER; BULIMIA; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DRUG EFFECT; FEEDING BEHAVIOR; FOOD INTAKE; HYPOPHAGIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; APPETITE DEPRESSANTS; DIETARY CARBOHYDRATES; DIETARY FATS; FEEDING BEHAVIOR; FLUOXETINE; FOOD DEPRIVATION; FOOD PREFERENCES; MALE; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0031415861     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00318-3     Document Type: Article

References (34)

1. American Psychiatric Association.: Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC; 1994.
2. Beczkowska I. W., Bodnar R. J. Naloxone and serotonin receptor subtype antagonists. Interactive effects upon deprivation-induced intake Pharmacol. Biochem. Behav. 38:1991;605-610.
3. Beebe D. W. Bulimia nervosa and depression. A theoretical and clinical appraisal in light of the binge-purge cycle Br. J. Clin. Psychiatry. 33:1994;259-276.
4. Bray G. A. Food intake, sympathetic activity, and adrenal steroids. Brain Res. Bull. 32:1993;537-541.
5. Cooper S. J., Dourish C. T., Barber D. T. Fluoxetine reduces food intake by a cholecystokinin-independent mechanism. Pharmacol. Biochem. Behav. 35:1990;51-54.
6. Cooper S. J., Turkish S. Effects of naltrexone on food preference and concurrent behavioral responses in food-deprived rats. Pharmacol. Biochem. Behav. 33:1989;17-20.
7. Fernandez-Tome M. P., Gonzalez Y., Del Rio J. Interaction between opioid agonists or naloxone and 5-HTP on feeding behavior in food-deprived rats. Pharmacol. Biochem. Behav. 29:1988;387-392.
8. Gillman M. A., Lichtigfeld F. J. Lithium and bulimia. The role of the dopaminergic and opiatergic systems Am. J. Psychiatry. 142:1985;12.
9. Giraudo S. Q., Grace M. K., Billington C. J., Levine A. S. Naloxone's anorectic effect is dependent upon the relative palatability of food. Pharmacol. Biochem. Behav. 46:1993;917-921.
10. Glass P. S., Jhaveri R. M., Smith L. R. Comparison of potency and duration of action of nalmefene and naloxone. Anesth Analg. 78:1994;536-541.
11. Gosnell B. A., Krahn D. D., Majchrzak M. J. The effects of morphine on diet selection are dependent upon baseline diet preferences. Pharmacol. Biochem. Behav. 37:1990;207-212.
12. Gosnell B. A., Morley J. E., Levine A. S. Opioid-induced feeding. Localization of sensitive brain sites Brain Res. 369:1984;177-184.
13. Hagan M. M., Moss D. E. Effect of naloxone and antidepressants on hyperphagia produced by peptide YY. Pharmacol. Biochem. Behav. 45:1993;941-944.
14. Hamagaki S. The dialectic of the obsessionality and the dissociativity. Toward a psychopathology of binge-eating Seishin Shinkeigaku Zasshi Psychiatr. Neurol. Jpn. 97:1995;1-30.
15. Islam A. K., Bodnar R. J. Selective opioid receptor antagonist effects upon intake of a high-fat diet in rats. Brain Res. 508:1990;293-296.
16. Kim S. H., Wurtman R. J. Selective effects of CGS 10686B, dl-fenfluramine or fluoxetine on nutrient selection. Physiol. Behav. 42:1988;319-322.
17. Koch J. E., Bodnar R. J. Selective alterations in macronutrient intake of food-deprived or glucoprivic rats by centrally administered opioid receptor subtype antagonists in rats. Brain Res. 657:1994;191-201.
18. Lawton C. L., Blundell J. E. 5-HT manipulation and dietary choice. Variable carbohydrate (Polycose) suppression demonstrated only under specific experimental conditions Psychopharmacology (Berlin). 112:1993;375-382.
19. Leibowitz S. F., Weiss G. F., Walsh U. A., Viswanath D. Medial hypothalamic serotonin. Role in circadian patterns of feeding and macronutrient selection Brain Res. 503:1989;132-140.
20. Luo S., Li E. T. Effect of 5-HT agonists on rats fed single diets with varying proportions of carbohydrate and protein. Psychopharmacology (Belrin). 109:1992;212-216.
21. Marks-Kaufman R., Kanarek R. Diet selection following a chronic morphine and naloxone regimen. Pharmacol. Biochem. Behav. 35:1990;665-669.
22. Marrazzi M. A., Kinzie J., Luby E. D. A detailed longitudinal analysis on the use of naltrexone in the treatment of bulimia. Int. Clin. Pharmacol. 10:1995;173-176.
23. Marrazzi M. A., Markham K. M., Kinzie J., Luby E. D. Binge eating disorder. Response to naltrexone Int. J. Obesity Related Metab. Disord. 19:1995;143-145.
24. Mason B. J., Ritvo E. C., Morgan R. O., Salvato F. R., Goldberg G., Welch B., Mantero-Atienza E. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCL for alcohol dependence. Alcohol. Clin. Exp. Res. 18:1994;1162-1167.
25. Mills I. H., Medlicott L. Anorexia nervosa as a compulsive behaviour disease. Q. J. Med. 83:1992;507-522.
26. Morley J. E., Levine A. S., Yim G. K. W., Lowy M. T. Opioid modulation of appetite. Neurosci. Biobehav. Rev. 7:1983;281-305.
27. Paez X., Leibowitz S. F. Changes in extracellular PVN monoamines and macronutrient intake after idazoxan or fluoxetine injection. Pharmacol. Biochem. Behav. 46:1993;933-941.
28. Robert J. J., Rouch C., Cohen Y., Jacquot C. Effects of dexfenfluramine and opioid peptides, alone or in combination on food intake and brain serotonin turnover in rats. Pharmacol. Biochem. Behav. 38:1990;775-780.
29. Russell G. Bulimia nervosa. An ominous variant of anorexia nervosa Psychol. Med. 9:1979;429-448.
30. Weiss G. F., Rogacki N., Fuel A., Buchen D., Suh J. S., Wong D. T., Leibowitz S. F. Effect of hypothalamic and peripheral fluoxetine injection on natural patterns of macronutrient intake in the rat. Psychopharmacology (Berlin). 105:1991;467-476.
31. Wood A. Pharmacotherapy of bulimia nervosa. Experience with fluoxetine Int. Clin. Psychopharmacol. 8:1993;295-299.
32. Woods J. S., Leibowitz S. F. Hypothalamic sites sensitive to morphine and naloxone. Effects on feeding behavior Pharmacol. Biochem. Behav. 23:1985;431-438.
33. Yamauchi A., Shizuka F., Yamamoto T., Nikawa T., Kido Y., Rokutan K., Kishi K. Amino acids and glucose differentially increased extracellular 5-hydroxyindoleacetic acid in the rat brain. J. Nutr. Sci. Vitaminol. 41:1995;325-340.
34. Yen T. T., Wong D. T., Bemis K. G. Reduction of food consumption and body weight of normal and obese mice by chronic treatment with fluoxetine. Drug Dev. Res. 10:1987;37-45.